SCHEMBL6826432

SCHEMBL6826432

Cc1ccc(SCc2ccc(C=O)s2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.40
ALDH1A1 P00352 8/20 0.40
POLB P06746 4/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 2/20 0.40
THRB P10828 1/20 0.40
TDP1 Q9NUW8 2/20 0.40
RECQL P46063 1/20 0.40
BLM P54132 1/20 0.40
ICAM1 P05362 1/20 0.38
SELE P16581 1/20 0.38
RAB9A P51151 6/20 0.37
NPC1 O15118 4/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
HTT P42858 3/20 0.37
HPGD P15428 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6826409 0.84 DAO (0.38) MAPTALDH1A1POLBL3MBTL1RECQL
SCHEMBL6829495 0.82 MAOA (0.43) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL510175 0.76 ALDH1A1 (0.45) MAPTALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL6829742 0.75 MAPT (0.40) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL6825954 0.70 L3MBTL1 (0.51) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL158329 0.69
SCHEMBL29020313 0.68 ALDH1A1 (0.44) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL20704671 0.68 CYP2A6 (0.57) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL6924355 0.68 ALDH1A1 (0.47) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL1680586 0.67 PRMT6 (0.47) MAPTALDH1A1POLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004037808-A1 2 - SUBSTITUTED HETEROCYCLIC COMPOUNDS AND ANTITUMOR COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2004-05-06 WO disclosed